Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB)

NCT00384891 is registered in ClinicalTrials.gov with Medical Enterprises Europe B.V. as lead sponsor.

NCT NCT00384891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00384891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study Comparing Adjuvant Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG Immunotherapy (BCG) Adjuvant Treatment in Patients With Superficial Transitional Cell Carcinoma of the Bladder (STCCB)
Lead sponsor
Medical Enterprises Europe B.V.
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2002
Completion date
December 31, 2013
Enrollment
190 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

malignant tumor of urinary bladder, neoplasms, neoplasms by site, urinary bladder cancer, urinary bladder diseases, urinary bladder neoplasms, urologic diseases, urologic neoplasms